Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 31 to 45 of 72 results for pulmonary embolism

  1. Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosis (IPG523)

    Evidence-based recommendations on ultrasound enhanced catheter-directed thrombolysis for deep vein thrombosis. This involves using ultrasound waves and a drug to break up the clot.

    Interventional procedures guidance
    Published
    26 June 2015
    View recommendations

    Sections for IPG523

  2. Percutaneous radiofrequency ablation for primary or secondary lung cancers (IPG372)

    Evidence-based recommendations on percutaneous radiofrequency ablation for primary or secondary lung cancers. This involves inserting 1 or more electrodes (needle-like probes) through the chest into the lung and using an electrical current to produce heat to destroy the cancer cells.

    Interventional procedures guidance
    Published
    15 December 2010
    View recommendations

    Sections for IPG372

  3. COVID-19 rapid guideline: managing COVID-19 (NG191)

    This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.

    COVID-19 rapid guideline
    Last updated
    8 May 2024

    Sections for NG191

  4. Laparoscopic techniques for hysterectomy (IPG239)

    Evidence-based recommendations on laparoscopic techniques for hysterectomy. This involves surgically removing the uterus using special instruments through small cuts in the abdomen (keyhole surgery).

    Interventional procedures guidance
    Published
    28 November 2007
    View recommendations

    Sections for IPG239

  5. Balloon angioplasty of pulmonary vein stenosis in infants (IPG75)

    Evidence-based recommendations on balloon angioplasty of pulmonary vein stenosis in infants. This involves involves inflating a balloon in the narrow section of the pulmonary vein to widen the area so blood can flow through more easily.

    Interventional procedures guidance
    Published
    28 July 2004
    View recommendations

    Sections for IPG75

  6. Research into the long-term treatment effects of rivaroxaban is needed.

    guidance details Comes from guidance Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism Number

    Research recommendation
    Published
    9 June 2015

  7. Further research on the clinical effectiveness of rivaroxaban compared with low molecular weight heparin (LMWH) in patients with active cancer should be conducted.

    vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism Number TA261 Date issued July 2012 Other

    Research recommendation
    Published
    9 June 2015

  8. Further research should be in the form of randomised controlled trials or registries. It should report:

    guidance Percutaneous thrombectomy for intermediate-risk or high-risk pulmonary embolism Number IPG778 Date issued November 2023

    Research recommendation
    Published
    11 January 2024

  9. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (NG128)

    This guideline covers interventions in the acute stage of a stroke or transient ischaemic attack (TIA). It offers the best clinical advice on the diagnosis and acute management of stroke and TIA in the 48 hours after onset of symptoms.

    NICE guideline
    Last updated
    13 April 2022
    View recommendations

    Sections for NG128

  10. Familial breast cancer. Patient decision aid on taking tamoxifen to reduce the chance of developing breast cancer for premenopausal women at moderately increased risk

    clot such as deep vein thrombosis (DVT) or a blood clot in the lungs (pulmonary embolism)? See pages 9-11 for more information and...

  11. Familial breast cancer. Patient decision aid on taking tamoxifen to reduce the chance of developing breast cancer for premenopausal women at high risk

    clot such as deep vein thrombosis (DVT) or a blood clot in the lungs (pulmonary embolism)? See pages 9-11 for more information and...

  12. Duration of prophylaxis for elective total hip replacement surgery:- What is the clinical and cost effectiveness of standard versus extended duration pharmacological prophylaxis for preventing VTE in people undergoing elective total hip replacement surgery?

    16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism Number NG89 Date issued March 2018 Other

    Research recommendation
    Published
    15 November 2018

  13. Reversal of the anticoagulant effect of dabigatran: idarucizumab (ESNM73)

    Summary of the evidence on idarucizumab for reversing the anticoagulant effect of dabigtatran to inform local NHS planning and decision-making

    Evidence summary
    Published
    24 May 2016

  14. Effects of HRT on venous thromboembolism risk:- How does the preparation of HRT affect the risk of venous thromboembolism (VTE)?

    important:- An increase in the risk of VTE (deep vein thrombosis [DVT] or pulmonary embolism [PE]) is a significant side effect of HRT,...

    Research recommendation
    Published
    11 December 2015

  15. Minimally invasive total hip replacement (IPG363)

    Evidence-based recommendations on minimally invasive total hip replacement. This involves replacing the damaged hip joint (the top part of the upper leg bone and the socket in the hip bone that it fits into) with an artificial one.

    Interventional procedures guidance
    Published
    27 October 2010
    View recommendations

    Sections for IPG363